{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:53:42Z","timestamp":1775656422038,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-03980-2","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T20:04:53Z","timestamp":1772568293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating bulk and single cell RNA sequencing to predict the potential therapeutic efficacy of DLX5 in hypopharyngeal squamous cell carcinoma"],"prefix":"10.1186","volume":"31","author":[{"given":"Yao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"4","key":"3980_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/RMR.0b013e3181570c3f","volume":"18","author":"ND Wycliffe","year":"2007","unstructured":"Wycliffe ND, Grover RS, Kim PD, et al. Hypopharyngeal cancer. Top Magn Reson Imaging. 2007;18(4):243\u201358.","journal-title":"Top Magn Reson Imaging"},{"key":"3980_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2016.06.024","volume":"65","author":"B Henriques De Figueiredo","year":"2016","unstructured":"Henriques De Figueiredo B, Fortpied C, Menis J, et al. Long-term update of the 24954 EORTC phase III trial on larynx preservation. Eur J Cancer. 2016;65:109\u201312.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3980_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/annonc\/mdy507","volume":"30","author":"M Oliva","year":"2019","unstructured":"Oliva M, Spreafico A, Taberna M, et al. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Ann Oncol. 2019;30(1):57\u201367.","journal-title":"Ann Oncol"},{"issue":"4","key":"3980_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2015.04.005","volume":"58","author":"AA Kolodziejczyk","year":"2015","unstructured":"Kolodziejczyk AA, Kim JK, Svensson V, et al. The technology and biology of single-cell RNA sequencing. Mol Cell. 2015;58(4):610\u201320.","journal-title":"Mol Cell"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2017.07.003","volume":"59","author":"E Hedlund","year":"2018","unstructured":"Hedlund E, Deng Q. Single-cell RNA sequencing: technical advancements and biological applications. Mol Aspects Med. 2018;59:36\u201346.","journal-title":"Mol Aspects Med"},{"issue":"8","key":"3980_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3980_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64162-w","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zou L, Tan F, et al. Screening of co-expressed genes in hypopharyngeal carcinoma with esophageal carcinoma based on RNA sequencing and clinical research. Sci Rep. 2024;14(1):13796.","journal-title":"Sci Rep"},{"issue":"5","key":"3980_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"3980_CR9","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, et al. Cell Marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3980_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1168191","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Guan R, Li W, et al. Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis. Front Immunol. 2023;14:1168191.","journal-title":"Front Immunol"},{"issue":"4","key":"3980_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"6190","key":"3980_CR12","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396\u2013401.","journal-title":"Science"},{"issue":"6476","key":"3980_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science. 2020;367(6476):405\u201311.","journal-title":"Science"},{"issue":"7","key":"3980_CR14","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, Flerin C, Davie K, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247\u201376.","journal-title":"Nat Protoc"},{"issue":"12","key":"3980_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/nmeth.2728","volume":"10","author":"JI Fuxman Bass","year":"2013","unstructured":"Fuxman Bass JI, Diallo A, Nelson J, et al. Using networks to measure similarity between genes: association index selection. Nat Methods. 2013;10(12):1169\u201376.","journal-title":"Nat Methods"},{"issue":"5","key":"3980_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"3980_CR17","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1128","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005. https:\/\/doi.org\/10.2202\/1544-6115.1128.","journal-title":"Stat Appl Genet Mol Biol."},{"key":"3980_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114747","volume":"193","author":"S Iliaki","year":"2021","unstructured":"Iliaki S, Beyaert R, Afonina IS. Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochem Pharmacol. 2021;193:114747.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"3980_CR19","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/ijbs.85656","volume":"19","author":"J Liao","year":"2023","unstructured":"Liao J, Chen Z, Chang R, et al. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. Int J Biol Sci. 2023;19(16):5218\u201332.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3980_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03277-y","volume":"20","author":"Y Huang","year":"2022","unstructured":"Huang Y, Li D, Wang L, et al. CENPF\/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2\/M-phase cell cycle. J Transl Med. 2022;20(1):78.","journal-title":"J Transl Med"},{"issue":"2","key":"3980_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00405-007-0420-z","volume":"265","author":"KEA Abou-Elhamd","year":"2008","unstructured":"Abou-Elhamd KEA, Habib TN. The role of chromosomal aberrations in premalignant and malignant lesions in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2008;265(2):203\u20137.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"3980_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ijc.20254","volume":"111","author":"SW Coon","year":"2004","unstructured":"Coon SW, Savera AT, Zarbo RJ, et al. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int J Cancer. 2004;111(2):206\u201312.","journal-title":"Int J Cancer"},{"issue":"21","key":"3980_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215313","volume":"13","author":"HAJ Kim","year":"2021","unstructured":"Kim HAJ, Shaikh MH, Lee M, et al. 3p arm loss and survival in head and neck cancer: an analysis of TCGA dataset. Cancers. 2021;13(21):5313.","journal-title":"Cancers"},{"issue":"4","key":"3980_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, et al. The human transcription factors. Cell. 2018;172(4):650\u201365.","journal-title":"Cell"},{"issue":"6","key":"3980_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3980_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067317","volume":"8","author":"Y Mizutani","year":"2013","unstructured":"Mizutani Y, Sun H, Ohno Y, et al. Cooperative synthesis of ultra long-chain fatty acid and ceramide during keratinocyte differentiation. PLoS ONE. 2013;8(6):e67317.","journal-title":"PLoS ONE"},{"issue":"28","key":"3980_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo5668","volume":"8","author":"H Huang","year":"2022","unstructured":"Huang H, Liu J, Li M, et al. Cis-regulatory chromatin loops analysis identifies GRHL3 as a master regulator of surface epithelium commitment. Sci Adv. 2022;8(28):eabo5668.","journal-title":"Sci Adv"},{"issue":"3","key":"3980_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cvr\/cvac159","volume":"119","author":"HW Lee","year":"2023","unstructured":"Lee HW, Adachi T, Pak B, et al. BMPR1A promotes ID2\u2013ZEB1 interaction to suppress excessive endothelial to mesenchymal transition. Cardiovasc Res. 2023;119(3):813\u201325.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"3980_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001394","volume":"19","author":"J Wang","year":"2021","unstructured":"Wang J, Farkas C, Benyoucef A, et al. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity. PLoS Biol. 2021;19(9):e3001394.","journal-title":"PLoS Biol"},{"issue":"21","key":"3980_CR30","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1007\/s00018-012-1254-4","volume":"70","author":"F Wang","year":"2013","unstructured":"Wang F, Marshall CB, Ikura M. Transcriptional\/epigenetic regulator CBP\/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell Mol Life Sci. 2013;70(21):3989\u20134008.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3980_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1139\/bcb-2020-0523","volume":"99","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wu J, Chen Y, et al. DLX5 promotes cancer progression through regulation of CCND1 in oral squamous cell carcinoma (OSCC). Biochem Cell Biol. 2021;99(4):424\u201334.","journal-title":"Biochem Cell Biol"},{"issue":"6","key":"3980_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. Oncopredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260.","journal-title":"Brief Bioinform"},{"issue":"3","key":"3980_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40265-023-01835-2","volume":"83","author":"A Bhatia","year":"2023","unstructured":"Bhatia A, Burtness B. Treating head and neck cancer in the age of immunotherapy: a 2023 update. Drugs. 2023;83(3):217\u201348. https:\/\/doi.org\/10.1007\/s40265-023-01835-2.","journal-title":"Drugs"},{"issue":"1","key":"3980_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01569-7","volume":"24","author":"S Babadi","year":"2024","unstructured":"Babadi S, Shahri MM, Nematollahi SF, et al. Relationship between NLR and penile squamous cell carcinoma: a systematic review and meta-analysis. BMC Urol. 2024;24(1):194.","journal-title":"BMC Urol"},{"key":"3980_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"3980_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"3980_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17(12):887\u2013904.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3980_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020323","volume":"14","author":"S Alavi","year":"2022","unstructured":"Alavi S, Emran AA, Tseng HY, et al. Nicotinamide inhibits T cell exhaustion and increases differentiation of CD8 effector T cells. Cancers (Basel). 2022;14(2):323.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3980_CR39","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jtcvs.2019.04.084","volume":"158","author":"KG Mitchell","year":"2019","unstructured":"Mitchell KG, Parra ER, Nelson DB, et al. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019;158(3):911-919.e6.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3980_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13073-022-01079-x","volume":"14","author":"M Yang","year":"2022","unstructured":"Yang M, Lin C, Wang Y, et al. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance. Genome Med. 2022;14(1):72.","journal-title":"Genome Med"},{"issue":"5","key":"3980_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra JC, Manne S, Abdel-Hakeem MS, Kurachi M, Giles JR, Chen Z, et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity. 2020;52(5):825-841.e8. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.014.","journal-title":"Immunity"},{"issue":"16","key":"3980_CR42","doi-asserted-by":"publisher","first-page":"9246","DOI":"10.1093\/nar\/gkab679","volume":"49","author":"Y Huang","year":"2021","unstructured":"Huang Y, Yang Q, Zheng Y, et al. Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma. Nucleic Acids Res. 2021;49(16):9246\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3980_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cub.2006.12.037","volume":"17","author":"M Steegmaier","year":"2007","unstructured":"Steegmaier M, Hoffmann M, Baum A, et al. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol. 2007;17(4):316\u201322.","journal-title":"Curr Biol"},{"issue":"20","key":"3980_CR44","doi-asserted-by":"publisher","first-page":"7880","DOI":"10.1021\/jm401463y","volume":"56","author":"M Narwal","year":"2013","unstructured":"Narwal M, Koivunen J, Haikarainen T, et al. Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. J Med Chem. 2013;56(20):7880\u20139.","journal-title":"J Med Chem"},{"issue":"24","key":"3980_CR45","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1200\/JCO.21.02541","volume":"40","author":"KK Ciombor","year":"2022","unstructured":"Ciombor KK, Strickler JH, Bekaii-Saab TS, et al. BRAF-mutated advanced colorectal cancer: a rapidly changing therapeutic landscape. J Clin Oncol. 2022;40(24):2706\u201315.","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03980-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:04:30Z","timestamp":1775653470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03980-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03980-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Medical Ethics Committee of Chaoyang Central Hospital. Committee Reference Number: EC-20231212-1041.This study obtained written informed consent from all participants before commencing. Participants voluntarily took part without any coercion and had fully understood the purpose, procedures, and potential risks and benefits of the study before signing the consent forms. The consent forms detailed the measures for the confidentiality of personal data and the rights of the participants to withdraw from the study at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"510"}}